共 84 条
- [1] Berger A(2004)Clinical characteristics and economic costs of patients with painful neuropathic disorders J Pain. 5 143-149
- [2] Dukes EM(2015)Improved neuropathic pain treatment in developing countries–a critical review of WHO essential list Pain. 156 763-764
- [3] Oster G(2016)Neuropathic low back pain in clinical practice Eur J Pain. 20 861-873
- [4] Soyannwo OA(2015)Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis The Lancet. Neurology. 14 162-173
- [5] Baron R(1998)Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA. 280 1831-1836
- [6] Finnerup NB(2006)painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain Curr Med Res Opin. 22 1911-1920
- [7] Backonja M(2008)Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey Acta Anaesthesiol Scand. 52 132-136
- [8] Freynhagen R(2000)Psychological aspects of neuropathic pain Clin J Pain. 16 S101-105
- [9] Baron R(1998)Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial JAMA. 280 1837-1842
- [10] Gockel U(2001)Pain in nursing home residents: management strategies Drugs Aging. 18 13-29